SGLT2 inhibitors (Atom Bioscience and Pharmaceutical)

N/A

Report date: 2025/01/19 10:49:14
NME

Base Information

Drug NameSGLT2 inhibitors (Atom Bioscience and Pharmaceutical)
Drug Alias NameSGLT2 inhibitors (type 2 diabetes), Atom Bioscience and Pharmaceutical
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/glucose cotransporter 2 inhibitors
TargetsSodium/glucose cotransporter 2
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangsu Atom Bioscience and Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Atom Bioscience and Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A